Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$58.54T
24h Vol:
$9.62B
Dominance:
MSFT:5.17%
Stocklytics Platform
BETA
Instrument logo  ABT

Abbott Laboratories

ABT
58 / 100
S&P500
$118.69arrow_drop_down-0.64%-$0.77

Performance History

Stocklytics logo
Key Stats
Open$119.38
Prev. Close$119.02
EPS3.26
Dividend$2.08
Next Earnings DateAug 13, 2024
Dividend Yield %1.84%
Market Cap$207.28B
PE Ratio36.64
LOWHIGH
Day Range118.86
120.15
52 Week Range89.67
120.15
Ratios
P/B Ratio5.37
Revenue$40.10B
Operating M. %20.09%
Earnings$5.72B
Earnings Growth %-17.45%
EBITDA Margin %26.09%
ROE %15.11%
EPS3.26

Score Breakdown

58vs 53. Market Avg.

All Score 58 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

ABTMARKET
Value2139
Quality5740
Ownership3519
Growth5746
Dividends3737
warning

Abbott Laboratories's Price growth average in the last 3 years of 0.13% is modest compared to market average of 6.1%. This indicates ABT could be a bad value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$771.91
24H (%)arrow_drop_up0.30%
24H ($)$2.38
MARKET CAP$733.45B
PRICE$525.32
24H (%)arrow_drop_down-0.36%
24H ($)-$1.91
MARKET CAP$485.88B
PRICE$160.78
24H (%)arrow_drop_down-0.64%
24H ($)-$1.05
MARKET CAP$387.30B
PRICE$128.84
24H (%)arrow_drop_down-0.47%
24H ($)-$0.61
MARKET CAP$326.48B

About Abbott Laboratories (ABT)

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Robert B. Ford
Headquarters
North Chicago
Employees
115000
Exchange
NYSE
add Abbott Laboratories to watchlist

Keep an eye on Abbott Laboratories

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
What is Abbott Laboratories's (ABT) price per share?

The current price per share for Abbott Laboratories (ABT) is $118.69. The stock has seen a price change of -$0.77 recently, indicating a -0.64% change. This reflects the stock's recent market performance and investor sentiment.

question_mark
What is the 52-week high and low for Abbott Laboratories (ABT)?

For Abbott Laboratories (ABT), the 52-week high is $120.15, which is 1.23% from the current price. The 52-week low is $89.67, the current price is 32.36% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

question_mark
Is Abbott Laboratories (ABT) a growth stock?

Abbott Laboratories (ABT) has shown an average price growth of 1.05% over the past three years. It has received a score of 54 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Abbott Laboratories as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

question_mark
What is Abbott Laboratories (ABT) stock price performance year to date (YTD)?

As of the latest data, Abbott Laboratories (ABT) has a year-to-date price change of 8.03%. Over the past month, the stock has experienced a price change of 4.61%. Over the last three months, the change has been 15.56%. Looking at a longer horizon, the five-year price change stands at 53.68%.

question_mark
Is Abbott Laboratories (ABT) a profitable company?

Abbott Laboratories (ABT) has a net income of $5.72B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 55.42% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 20.09% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $40.11B, although specific revenue growth data is currently not available. The gross profit is $22.23B. Operating income is noted at $6.69B. Furthermore, the EBITDA is $10.58B.

question_mark
What is the market capitalization of Abbott Laboratories (ABT)?

Abbott Laboratories (ABT) has a market capitalization of $205.95B. The average daily trading volume is 5.35M, indicating the stock's liquidity and investor engagement.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.